India's vaccine wait over: Serum Institute, Bharat Biotech get approval
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SATURDAY, MAY 28, 2022
SATURDAY, MAY 28, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
India's vaccine wait over: Serum Institute, Bharat Biotech get approval

Coronavirus chronicle

TBS Report
03 January, 2021, 11:50 am
Last modified: 03 January, 2021, 12:33 pm

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • US donates 3 million doses of Covid vaccine to Bangladesh
  • Moderna to seek regulatory approval for Covid shot for very young children
  • Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
  • Inoculation of shop-owners, workers begins in capital

India's vaccine wait over: Serum Institute, Bharat Biotech get approval

Both Covishield and Covaxin received emergency approval for restricted use

TBS Report
03 January, 2021, 11:50 am
Last modified: 03 January, 2021, 12:33 pm
India's vaccine wait over: Serum Institute, Bharat Biotech get approval

 

Two vaccines for coronavirus, Serum Institute's Covishield and Bharat Biotech's Covaxin, received emergency approval from India's drug regulator today, according to Bew Delhi Television Ltd (NDTV).

Both of the firms submitted their trial run data, according to The Drug Controller General of India VG Somani.

''Both have been granted permission for restricted use,'' he added. 

Top News / South Asia

Covid vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: TBS
    After 72-hour ultimatum, health directorate goes after illegal medical facilities 
  • Photo: Bloomberg
    Direct shipping now to Netherlands 
  • The guy on the right just did a solid for the guy on the left.Photographer: Alex Kraus/Bloomberg
    Rishi Sunak’s helicopter drop makes the bank of England’s life easier

MOST VIEWED

  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    'Tomorrow will be better': Shanghai inches towards Covid re-opening
  • North Korea says new fever cases under 100,000 as virus fight heats up
    North Korea says new fever cases under 100,000 as virus fight heats up
  • People in protective suits cross a street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    Shanghai heading out of lockdown but China still lost in economic gloom
  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules
  • A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
    Pfizer says 3 Covid shots protect children under 5

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • US donates 3 million doses of Covid vaccine to Bangladesh
  • Moderna to seek regulatory approval for Covid shot for very young children
  • Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
  • Inoculation of shop-owners, workers begins in capital

Features

Illustration: Freepik

Bangladesh is on the verge of destigmatising menstruation

2h | Features
Photo: Collected

The death of Davos?

8h | Panorama
A male Baya Weaver beating wings. Photo: Enam Ul Haque

Baya Weavers weave: ‘Must be witnessed to be fully credited’

12h | Panorama
Starlink is ideal in rural or remote locations where internet access has been unreliable or completely unavailable. Photo: SpaceX

Time for a reality check: How viable is Starlink in Bangladesh?

13h | Panorama

More Videos from TBS

Attorney General's suggestion to reduce case clutter

Attorney General's suggestion to reduce case clutter

2h | Videos
Russian forces take Liman city of Ukraine

Russian forces take Liman city of Ukraine

2h | Videos
JU food prices spike, students suffer

JU food prices spike, students suffer

2h | Videos
5% tax on poultry farmers earning above Tk10 lakh

5% tax on poultry farmers earning above Tk10 lakh

2h | Videos

Most Read

1
Bangladesh Bank GM, DGM’s designation changed
Banking

Bangladesh Bank GM, DGM’s designation changed

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

5
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab